432 related articles for article (PubMed ID: 36101390)
21. The role of liquid-liquid phase separation in aggregation of the TDP-43 low-complexity domain.
Babinchak WM; Haider R; Dumm BK; Sarkar P; Surewicz K; Choi JK; Surewicz WK
J Biol Chem; 2019 Apr; 294(16):6306-6317. PubMed ID: 30814253
[TBL] [Abstract][Full Text] [Related]
22. Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell Death.
Gasset-Rosa F; Lu S; Yu H; Chen C; Melamed Z; Guo L; Shorter J; Da Cruz S; Cleveland DW
Neuron; 2019 Apr; 102(2):339-357.e7. PubMed ID: 30853299
[TBL] [Abstract][Full Text] [Related]
23. How do RNA binding proteins trigger liquid-liquid phase separation in human health and diseases?
Huai Y; Mao W; Wang X; Lin X; Li Y; Chen Z; Qian A
Biosci Trends; 2022 Dec; 16(6):389-404. PubMed ID: 36464283
[TBL] [Abstract][Full Text] [Related]
24. Potential Therapeutic Role of HDAC Inhibitors in FUS-ALS.
Tejido C; Pakravan D; Bosch LVD
Front Mol Neurosci; 2021; 14():686995. PubMed ID: 34434087
[TBL] [Abstract][Full Text] [Related]
25. Combating deleterious phase transitions in neurodegenerative disease.
Darling AL; Shorter J
Biochim Biophys Acta Mol Cell Res; 2021 Apr; 1868(5):118984. PubMed ID: 33549703
[TBL] [Abstract][Full Text] [Related]
26. Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43.
Watanabe S; Inami H; Oiwa K; Murata Y; Sakai S; Komine O; Sobue A; Iguchi Y; Katsuno M; Yamanaka K
Cell Death Dis; 2020 Oct; 11(10):909. PubMed ID: 33097688
[TBL] [Abstract][Full Text] [Related]
27. ALS-linked FUS mutations dysregulate G-quadruplex-dependent liquid-liquid phase separation and liquid-to-solid transition.
Ishiguro A; Lu J; Ozawa D; Nagai Y; Ishihama A
J Biol Chem; 2021 Nov; 297(5):101284. PubMed ID: 34624313
[TBL] [Abstract][Full Text] [Related]
28. The N-terminal domain of the prion protein is required and sufficient for liquid-liquid phase separation: A crucial role of the Aβ-binding domain.
Kamps J; Lin YH; Oliva R; Bader V; Winter R; Winklhofer KF; Tatzelt J
J Biol Chem; 2021 Jul; 297(1):100860. PubMed ID: 34102212
[TBL] [Abstract][Full Text] [Related]
29. Granulins modulate liquid-liquid phase separation and aggregation of the prion-like C-terminal domain of the neurodegeneration-associated protein TDP-43.
Bhopatkar AA; Uversky VN; Rangachari V
J Biol Chem; 2020 Feb; 295(8):2506-2519. PubMed ID: 31911437
[TBL] [Abstract][Full Text] [Related]
30. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS.
Ito D; Suzuki N
Neurology; 2011 Oct; 77(17):1636-43. PubMed ID: 21956718
[TBL] [Abstract][Full Text] [Related]
31. Sedimentation Assays to Assess the Impact of Posttranslational Modifications on Phase Separation of RNA-Binding Proteins In Vitro and In Cells.
Gruijs da Silva LA; Dormann D
Methods Mol Biol; 2023; 2563():325-339. PubMed ID: 36227481
[TBL] [Abstract][Full Text] [Related]
32. TDP-43 and FUS en route from the nucleus to the cytoplasm.
Ederle H; Dormann D
FEBS Lett; 2017 Jun; 591(11):1489-1507. PubMed ID: 28380257
[TBL] [Abstract][Full Text] [Related]
33. Phase separation of RNA-binding proteins in physiology and disease: An introduction to the JBC Reviews thematic series.
Shorter J
J Biol Chem; 2019 May; 294(18):7113-7114. PubMed ID: 30948513
[TBL] [Abstract][Full Text] [Related]
34. Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites.
Yoshizawa T; Ali R; Jiou J; Fung HYJ; Burke KA; Kim SJ; Lin Y; Peeples WB; Saltzberg D; Soniat M; Baumhardt JM; Oldenbourg R; Sali A; Fawzi NL; Rosen MK; Chook YM
Cell; 2018 Apr; 173(3):693-705.e22. PubMed ID: 29677513
[TBL] [Abstract][Full Text] [Related]
35. Synaptic Paths to Neurodegeneration: The Emerging Role of TDP-43 and FUS in Synaptic Functions.
Ling SC
Neural Plast; 2018; 2018():8413496. PubMed ID: 29755516
[TBL] [Abstract][Full Text] [Related]
36. Hormone-Inducible Transport Reporter Assay to Study Nuclear Import Defects in Neurodegenerative Diseases.
Hutten S; Dormann D
Methods Mol Biol; 2022; 2502():81-90. PubMed ID: 35412232
[TBL] [Abstract][Full Text] [Related]
37. Loss of Dynamic RNA Interaction and Aberrant Phase Separation Induced by Two Distinct Types of ALS/FTD-Linked FUS Mutations.
Niaki AG; Sarkar J; Cai X; Rhine K; Vidaurre V; Guy B; Hurst M; Lee JC; Koh HR; Guo L; Fare CM; Shorter J; Myong S
Mol Cell; 2020 Jan; 77(1):82-94.e4. PubMed ID: 31630970
[TBL] [Abstract][Full Text] [Related]
38. RNA-Binding Proteins in Amyotrophic Lateral Sclerosis and Neurodegeneration.
Ugras SE; Shorter J
Neurol Res Int; 2012; 2012():432780. PubMed ID: 22919483
[TBL] [Abstract][Full Text] [Related]
39. Role and therapeutic potential of liquid-liquid phase separation in amyotrophic lateral sclerosis.
Pakravan D; Orlando G; Bercier V; Van Den Bosch L
J Mol Cell Biol; 2021 Apr; 13(1):15-28. PubMed ID: 32976566
[TBL] [Abstract][Full Text] [Related]
40. A Quantitative Heterokaryon Assay to Measure the Nucleocytoplasmic Shuttling of Proteins.
McNicoll F; Müller-McNicoll M
Bio Protoc; 2018 Sep; 8(17):e2472. PubMed ID: 34395784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
